USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
USA Territories: American Samoa (USA); Guam (USA); Puerto Rico (USA); Virgin Islands (USA); Northern Mariana Islands (USA)
USA Compact Free Associations: The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA)
Canada: Alberta; British Columbia; Manitoba; New Brunswick; Newfoundland and Labrador; Northwest Territories; Nova Scotia; Nunavut; Ontario; Prince Edward Island; Quebec; Saskatchewan; Yukon
Israel
International country outside of the USA, Israel and Canada.
Award to a USA, Canada, or International scientist for outstanding research related to lupus. Nominations will be accepted for researchers who are affiliated with academic, research, government, biomedical, pharmaceutical, or biotechnological institutions. The primary objective of the Lupus Insight Prize is to identify and recognize an outstanding investigator who has developed a novel research insight in scientific domains relevant to lupus. The recipient of the Lupus Insight Prize will be honored at a public ceremony at the FOCIS Annual Meeting in June 2023. The recipient is expected to deliver a lecture describing their discovery/insight, the past work that resulted in the insight, and the planned research as it relates to lupus.
The Lupus Research Alliance (LRA) requests nominations for the 2023 Lupus Insight Prize recognizing and honoring significant scientific insights relevant to understanding the causes, pathogenesis, or treatment of lupus. The Prize also aims to stimulate further advances leading to improved outcomes for lupus patients and ultimately to a cure.
The Lupus Insight Prize provides research funds to an outstanding investigator with a documented record of creativity, innovation, and productivity who has made a novel insight or discovery in a research area applicable to the pathogenesis or treatment of lupus. The investigator must have a high likelihood of generating further significant advances by applying the insight to lupus.
The Prize is not a lifetime achievement award. Rather, the Lupus Insight Prize will be given for a specific, significant, and recent (within the past five years) discovery relevant to lupus.
In addition to recognizing a specific insight or discovery, the Prize also aims to direct the talents of the Prize recipient toward further high impact research achievement and testing of the insight in lupus. This should shift the current paradigms and significantly advance the understanding or treatment of lupus. Secondary objectives of the Prize are to: (1) raise the visibility of lupus as a significant medical condition among the general public and (2) demonstrate the determination of the LRA to surmount the challenges of this complex and debilitating disease through the support of research.
Nominees for the Lupus Insight Prize will be evaluated based on the scientific discovery/insight for which they are being nominated. Specifically, nominations will be judged based on 1) the novelty and significance of the discovery/insight, 2) the likelihood of its successful further application to lupus or further development within lupus, and 3) the potential of the discovery/insight to ultimately impact lupus patients.
The institution of the Prize recipient, unless the recipient is working for a biotechnology or a pharmaceutical company, will receive funds to be used at the discretion of the recipient with the expectation that the funds will be used to apply the discovery/insight for which the Prize was awarded toward advancing understanding of the genetic, environmental, molecular, immunologic, or cellular aspects of lupus or its treatment.
Estimated Size of Grant:
Submit nomination materials to Diomaris Gonzalez at dgonzalez@lupusresearch.org.
Inquiries:
Scientific:
Jana Barlic-Dicen, PhD
Scientific Program Manager
Lupus Research Alliance
jbarlicdicen@lupusresearch.org
+1-646-884-6086
Administrative:
Diomaris Gonzalez
Director, Grant Programs
Lupus Research Alliance
dgonzalez@lupusresearch.org
+1-646-884-6056